1887
  1. Home
  2. BSAVA Small Animal Formulary Part A: Canine and Feline
  3. Spironolactone
Spironolactone
; https://doi.org/
/content/dataitem/canine-and-feline/spironolactone

Spironolactone

Online Access: Subscribe
This is a drug monograph from the BSAVA Small Animal Formulary Part A: Canine and Feline. BSAVA members should login for access to the full monograph. Non-members can join BSAVA, buy a Formulary subscription, or buy the printed edition. 
  1. James RA ,Guillot E ,Gilmour J et al.(2015)Efficacy of Spironolactone (SP) Following Oral Administration of SP in Cats with Heart Failure: Final Results of the SEISICAT Study. Proceedings of the 25th ECVIM-CA Congress, Lisbon
  2. Lefebvre HP ,Ollivier E ,Atkins CE et al.(2013)Safety of spironolactone in dogs with chronic heart failure because of degenerative valvular disease: a population-based, longitudinal study. Journal of Veterinary Internal Medicine 27 ,1083–1091
  3. Ash RA, Harvey AM and Tasker S (2005) Primary hyperaldosteronism in the cat: a series of 13 cases.Journal of Feline Medicine and Surgery 7, 173–182
    4.
  4. Bernay F, Bland JM, Haggstrom J et al.(2010) Efficacy of spironolactone on survival in dogs with naturally occurring mitral regurgitation caused by myxomatous mitral valve disease.Journal of Veterinary Internal Medicine 24, 331–341
    5.
  5. Jeunesse E, Woehrle F, Schneider M and Lefebvre HP (2007) Effect of spironolactone on diuresis and urine sodium and potassium excretion in healthy dogs.Journal of Veterinary Cardiology 9, 63–68
    6.
  6. Pitt B (2004) Effect of aldosterone blockade in patients with systolic left ventricular dysfunction: implications of the RALES and EPHESUS studies.Molecular and Cellular Endocrinology 217, 53–58
    7.
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error